During the past decade, Green Bay Oncology Limited at Saint Mary's Hospital conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 189 clinical trials were completed, i.e. on average, 609.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 65 clinical trials were completed. i.e. 6500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Green Bay Oncology Limited at Saint Mary's Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 81 trials, followed by "Alliance for Clinical Trials in Oncology" with 74 trials sponsored, "SWOG Cancer Research Network" with 33 trials sponsored, "Eastern Cooperative Oncology Group" with 18 trials sponsored and "Radiation Therapy Oncology Group" with 18 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Green Bay Oncology Limited at Saint Mary's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 182 trials as a collaborator, "NRG Oncology" with 29 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator, "NCIC Clinical Trials Group" with 14 trials as a collaborator and "SWOG Cancer Research Network" with 12 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Green Bay Oncology Limited at Saint Mary's Hospital" are "Breast Cancer" (37 trials), "Lung Cancer" (21 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (13 trials), "Lymphoma" (11 trials) and "Prostate Cancer" (11 trials). Many other conditions were trialed in "Green Bay Oncology Limited at Saint Mary's Hospital" in a lesser frequency.

Most popular intervention types in "Green Bay Oncology Limited at Saint Mary's Hospital" are "Drug" (231 trials), "Other" (141 trials), "Biological" (86 trials), "Radiation" (38 trials) and "Procedure" (35 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (75 trials), "Quality-of-Life Assessment" (36 trials), "placebo" (32 trials), "Paclitaxel" (27 trials) and "Bevacizumab" (23 trials). Other intervention names were less common.

The vast majority of trials in "Green Bay Oncology Limited at Saint Mary's Hospital" are 194 trials for "All" genders, 64 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Green Bay Oncology Limited at Saint Mary's Hospital". undefined are not yet recruiting, 5 are recruiting, 69 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 173 completed trials in Green Bay Oncology Limited at Saint Mary's Hospital, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Green Bay Oncology Limited at Saint Mary's Hospital, 11 "Phase 1" clinical trials were conducted, 116 "Phase 2" clinical trials and 136 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Green Bay Oncology Limited at Saint Mary's Hospital has several departments that took part in Clinical trials: "Green Bay Oncology at Saint Vincent Hospital" - 142 trials, "Green Bay Oncology-Manistique" - 2 trials